Phio Pharmaceuticals Corp.

04/22/2024 | Press release | Distributed by Public on 04/22/2024 11:16

Intratumoral Injection of Phio's PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cells